Cargando…
Association of Diffusion and Anatomic Imaging Parameters with Survival for Patients with Newly Diagnosed Glioblastoma Participating in Two Different Clinical Trials()
PURPOSE: To evaluate the time course and association with survival of anatomic lesion volumes and diffusion imaging parameters for patients with newly diagnosed glioblastoma who were treated with radiation and concurrently with either temozolomide and enzastaurin (TMZ+enza cohort) or temozolomide, e...
Autores principales: | Wen, Qiuting, Jalilian, Laleh, Lupo, Janine M., Li, Yan, Roy, Ritu, Molinaro, Annette M., Chang, Susan M., Prados, Michael, Butowski, Nicholas, Clarke, Jennifer, Nelson, Sarah J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700297/ https://www.ncbi.nlm.nih.gov/pubmed/26692525 http://dx.doi.org/10.1016/j.tranon.2015.10.001 |
Ejemplares similares
-
Comparison of ADC metrics and their association with outcome for patients with newly diagnosed glioblastoma being treated with radiation therapy, temozolomide, erlotinib and bevacizumab
por: Wen, Qiuting, et al.
Publicado: (2014) -
Serial analysis of 3D H-1 MRSI for patients with newly diagnosed GBM treated with combination therapy that includes bevacizumab
por: Nelson, Sarah J., et al.
Publicado: (2016) -
Characterization of Metabolic, Diffusion, and Perfusion Properties in GBM: Contrast-Enhancing versus Non-Enhancing Tumor()()
por: Autry, Adam, et al.
Publicado: (2017) -
Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021) -
Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)